Table 1.
Literature reports of autophagy in the insulin resistant or diabetic heart
Autophagy | Model |
Autophagy Measurement | Duration of Diabetes | Akt Activity | AMPK Activity | Reference | |
---|---|---|---|---|---|---|---|
↑ | Fructose-fed mouse | T2D | ↑ LC3BII:I ratio, Beclin1, p62 protein | 12 wk | ↓ | ↔* | 59 |
↑ | Goto-Kakizaki rat | T2D | ↑ LC3BI, LC3BII, LC3BII:I ratio, Beclin1, Atg12-Atg5, Atg7 protein | 18 wk old | nr | ↑ | 50 |
↑ | STZ-mouse (x5 inj) | T1D | ↑ LC3II:I ratio#, p62, Beclin1 protein | 16 wk | nr | nr | 93 |
↑ autophagosomes (EM) | |||||||
↑ Atg5, Atg12, Beclin1 mRNA | |||||||
↔ LC3#, p62 mRNA | |||||||
↑ | STZ rat (x1 inj) | T1D | ↑ LC3BII:I ratio | 8 wk | ↓ | nr | 61 |
↑ | STZ rat (x1 inj) | T1D | ↑LC3# puncta | 4 wk | nr | nr | 49 |
↑ LC3II:I ratio#, Beclin1 protein | |||||||
↑ | High-fat fed mouse | ins res | ↑ Beclin1, LAMP2A mRNA | 24 wk | nr | nr | 4 |
↑ | High-fat fed mouse | ins res | ↑ LC3B, Beclin1 mRNA | 18 wk | nr | nr | 78 |
↑ LC3B puncta | |||||||
↑ | STZ mouse (x1 inj) | T1D | ↑LC3BII, CathepsinD protein | 7 wk | nr | nr | 12 |
↓ p62 protein | |||||||
↔ | T2D humans | T2D | ↔ LC3II:I ratio# | 7–20 yr | nr | nr | 62 |
↔ | High-fat fed rat | ins res | ↔ LC3II:I ratio#, Beclin1, LAMP1 protein | 10 wk | nr | nr | 57 |
↔ | High fat-STZ rat | T2D | ↔ LC3II:I ratio#, Beclin1, LAMP1 protein | 8 wk | nr | nr | 57 |
↔ | High-fat fed mouse (female) | ins res | ↔ LC3II:I ratio#, ↔ Atg5 mRNA | 10–12 wk | nr | nr | 47 |
↔ | pancreatectomy rats | T1D | ↔LC3II:I ratio#, p62 protein | 11 wk | ↔ | nr | 48 |
↓ | High-fat fed mouse | ins res | ↓ LC3BII:I ratio, LC3BII, Beclin1 protein | 20 wk | ↑ | nr | 104 |
↑ p62 protein | |||||||
↑ pULK1/ULK1, ↔ LC3BI | |||||||
↓ | High-fat fed mouse | ins res | ↓ LC3BII:I ratio, LC3BII protein | 22 wk | nr | ↓ | 23 |
↑ p62 protein | |||||||
↔ LC3BI, Beclin1 protein | |||||||
↓ | High-fat fed mouse | ins res | ↓ LC3II:I ratio# | 8 wk | nr | ↔ | 6 |
↓ | High-fat fed mouse | ins res | ↓ LC3II:I ratio (ns)#, ↑ p62 protein | 12 wk | nr | nr | 28 |
↓ | db/db mouse | T2D | ↓ LC3II:I ratio# | 14–18 wk old | ↓ | ↔ | 73 |
↔Beclin1, Atg12-Atg5 protein | |||||||
↓ | High-fat fed mouse | ins res | ↓ LC3II# protein | 18–20 wk | ↔ | ↓ | 82 |
↓ | STZ mouse (x1 inj) | T1D | ↓ LC3II#, Atg12, Atg12-Atg5 protein | 6, 9, 12 wk | ↑ | ↓ | 103 |
↓ LC3 protein (Baf-Con) | |||||||
↓ LC3 puncta (Baf-Con) | |||||||
↓ | STZ mouse (x5 inj) | T1D | ↓ LC3II#, Beclin1 protein | 8 wk | ↓ | ↓ | 110 |
↓ | STZ mouse (x5 inj) | T1D | ↓ LC3BII protein | 16 wk | ↓ | ↓ | 29 |
↓ | STZ mouse (x5 inj) | T1D | ↓ LC3II protein# | 16 wk | nr | ↓ | 101 |
↓ | OVE26 mouse | T1D | ↓ LC3II protein# | 40 wk old | nr | ↓ | 101 |
↓ autophagic vacuoles (EM) | |||||||
↓ Beclin1 staining (IHC) | |||||||
↓ | db/db mouse | T2D | ↓ LC3II# (+Baf, sample blot) | 10–14 wk old | nr | nr | 57 |
Ambiguous | High-fat fed mouse | ins res | ↑ LC3BI, LC3BII, p62 protein | 20 wk | ↑tAkt2 | ↓ | 102 |
↑ LC3, p62 mRNA | |||||||
↑ double membrane-bound vacuole/cell | |||||||
↔LC3BII:I ratio, Beclin1 protein | |||||||
CQ-induced LC3BII increase abrogated |
nr, not reported; STZ, streptozotocin; T2D, type 2 diabetes; T1D, type 1 diabetes; Atg, autophagy; ns, not significant; ins res, insulin resistance; LAMP, lysosome associated membrane protein 1; Baf-Con, bafilomycin-control; EM, electron microscopy; CQ, chloroquine. ↑, Diabetes-induced increase; ↓, diabetes-induced decrease; ↔, no effect of diabetes.
Personal communication; #LC3 isoform nonselective antibody used. All data presented are obtained in the absence of lysosomal inhibition unless otherwise noted.